| 摘要 |
<p>Use of buprenorphine for abuse protection in pharmaceutical compositions containing at least one opioid full-agonist, is claimed. An independent claim is included for a pharmaceutical composition comprising at least one opiate full agonist or its salt, and buprenorphine or its salt, where the buprenorphine or its salt is continuously released over a period of 30 minutes to 8 hours after oral administration. ACTIVITY : Antiaddictive. MECHANISM OF ACTION : None given.</p> |
